Lung cancer screening with low dose CT requires careful consideration
Research output: Contribution to journal › Review › Research › peer-review
Results from the American National Lung Screening Trial (NLST) show a significant reduction in lung cancer and all-cause mortality in a high risk population screened with annual low-dose CT. Handling of pulmonary nodules, false positive tests, overdiagnosis, psychosocial consequences and cost-efficiency etc. are all aspects that require careful consideration. This paper gives an overview of the current knowledge on these issues. Before a recommendation can be made, we need an overall evaluation of both the benefits and harms in CT screening for lung cancer.
|Journal||Ugeskrift for Laeger|
|Publication status||Published - 13 Oct 2014|